HerNostics
AboutTechnologyProductsResearchImpactPartnersArticlesCareersPartner with us
Technology platform

The science under the surface.

An electrochemical sensing stack combining advanced nanomaterials with paper microfluidics to deliver lab-grade detection at the point of care — engineered for sensitivity, reproducibility, and low-cost manufacturing.

Technology platform

The science under the surface.

An electrochemical sensing stack that combines advanced nanomaterials with paper microfluidics to deliver lab-grade detection at the point of care.

01

Electrochemical biosensors

Direct, quantitative signal transduction from sample to digital readout.

02

Pd–Ti₃C₂ MXene sensing

2D nanomaterials that amplify sensitivity and lower the detection limit.

03

Paper microfluidics

Capillary-driven fluid handling — no pumps, low cost, single use.

04

Carbon screen-printed electrodes

Mass-manufacturable sensing surfaces engineered for reproducibility.

05

Nanomaterial-enabled sensing

Surface chemistry tuned for selective capture of target hormones.

06

Digital health integration

Portable analytics and trend tracking, ready for connected care.

Scientific validation

Measured, not marketed.

Performance demonstrated through prototype validation studies, including evaluation across patient samples at SGPGI, Lucknow.

Detection limit
mIU/mL
Sensitivity at the low end of the clinical range.
Dynamic range
mIU/mL
Spans baseline through the full LH surge.
Result time
min
From sample to digital result.
Clinical accuracy
%
Agreement in prototype validation.
Stability
days
Strip shelf-stability under study conditions.
Reproducibility
% RSD
Consistency across repeated measurements.